Antares Therapeutics is a clinical-stage small molecule biopharmaceutical company developing oral and injectable therapies for autoimmune and inflammatory diseases. The company is headquartered in Princeton, New Jersey, and was acquired by Novartis in 2026.
Company Info
Funding & Investor Relations
N/A (private; acquired)
Upcoming Milestones & Key Dates
Phase 2 ATRS-101 topline readout (psoriasis)
AHA Scientific Sessions
Clinical Development Pipeline
Recent News
Novartis entered a small molecule discovery partnership with Antares Therapeutics, paying $105M upfront plus milestones to access Antares' inflammation and immunology pipeline.
Leadership Team
Chief Executive Officer
Chief Operating Officer
Chief Medical Officer
Careers & Job Openings